Directors & Officers
As of July 1, 2023
OutsideOutside Director
IndependentIndependent officer pursuant to Article 436-2 of the regulations of Tokyo Stock Exchange, Inc.
Directors
![]() |
Dr. Osamu OkudaRepresentative Director, President & CEO Supervisory responsibility for Corporate Planning, ASPIRE Transformation, Business Transformation, Partnering, External Affairs and Audit In charge of Partnering Dept., External Affairs Dept., and Audit Dept.
|
![]() |
Dr. Hisafumi YamadaDirector, Executive Vice President Supervisory responsibility for Project & Lifecycle Management (R&D), Research, Translational Research, Clinical Development, Pharmaceutical Technology and Manufacturing Technology
|
![]() |
Toshiaki ItagakiDirector, Executive Vice President & CFO Supervisory responsibility for Finance & Accounting, Corporate Communication and Procurement
|
![]() |
Dr. Mariko Y Momoi
Professor Emeritus of Jichi Medical University Visiting Professor of School of Medicine, Shinshu University Regent of Tokyo Medical University (part-time)
|
![]() |
Dr. Fumio Tateishi
Honorary Advisor of OMRON Corporation
|
![]() |
Hideo Teramoto
President of Dai-ichi Life Research Institute, Inc. Outside Director of Imperial Hotel, Ltd.
|
![]() |
Dr. Christoph Franz
Vice-Chairman of the Board of Directors of Zurich Insurance Group Ltd. (Switzerland) Member of the Board of Directors of Stadler Rail Ltd. (Switzerland)
|
![]() |
Dr. James H. Sabry
Global Head of Roche Pharma Partnering and Member of the Roche Enlarged Corporate Executive Committee
|
![]() |
Teresa A. Graham
CEO of Roche Pharmaceuticals, Member of the Roche Corporate Executive Committee
|
Audit & Supervisory Board Members
![]() |
Dr. Yoshiaki Ohashi
Audit & Supervisory Board Member (full-time)
|
![]() |
Dr. Shigehiro Yamada
Audit & Supervisory Board Member (full-time)
|
![]() |
Takaaki NimuraRepresentative of Nimura Certified Public Accountant Office
|
![]() |
Kenichi Masuda
Partner of Anderson Mōri & Tomotsune Outside Director of Bridgestone Corporation Outside Audit & Supervisory Board Member of Mercuria Holdings Co., Ltd.
|
![]() |
Yumiko Waseda
Partner Attorney-at-Law/Partner Patent Attorney, Tokyo Roppongi Law and Patent Office Outside Audit & Supervisory Board Member of IHI Corporation
|
Executive Officers
- Tetsuya Yamaguchi
- Executive Vice President
Supervisory responsibility for Project & Lifecycle Management (Marketing), Drug Safety, Medical Affairs and Foundation Medicine
Head of Project & Lifecycle Management Unit and Head of Foundation Medicine Unit - Junichi Ebihara
- Executive Vice President
Supervisory responsibility for Legal, Intellectual Property, General Affairs, Risk Management, Compliance and Quality & Regulatory Compliance
In charge of Legal Dept., Intellectual Property Dept. and General Affairs Dept. - Shinji Hidaka
- Executive Vice President
Supervisory responsibility for Marketing & Sales
Head of Marketing & Sales Div. - Yoshiyuki Yano
- Executive Vice President
Supervisory responsibility for Human Resource Management and EHS
In charge of Human Resources Management Dept. - Satoko Shisai
- Executive Vice President
Supervisory responsibility for Digital Transformation
Head of Digital Transformation Unit - Iwaaki Taniguchi
- Senior Vice President
Head of Finance Supervisory Div. and Head of Finance & Accounting Dept. - Tsukasa Kusano
- Vice President
Head of Clinical Development Div. - Dr. Kaori Ouchi
- Vice President
Head of Drug Safety Div. - Shinya Takuma
- Vice President
Head of Manufacturing Technology Div. and Chugai Pharma Manufacturing Co., Ltd. (President) - Dr. Hitoshi Iikura
- Vice President
Head of Research Div. - Masayoshi Higuchi
- Vice President
Head of Quality & Regulatory Compliance Unit
In charge of Risk & Compliance Dept. - Norihisa Onozawa
- Vice President
Head of Corporate Planning Dept.
In charge of ASPIRE Transformation Dept. and Business Transformation Dept.